<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775007</url>
  </required_header>
  <id_info>
    <org_study_id>2008-P-002176/10</org_study_id>
    <nct_id>NCT01775007</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer</brief_title>
  <acronym>Brillouin I</acronym>
  <official_title>A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Brillouin ocular analyzer uses a low-power near infrared laser light to probe the
      viscoelastic properties of the cornea and crystalline lens in the eye. The study hypothesis
      is that the instrument can measure the Brillouin light scattering spectra from the eye safely
      and effectively from human subjects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>6 months</time_frame>
    <description>Complete standard eye exam including medical and ocular history with manifest refraction, Amsler grid evaluation (macular test), color vision (Ishihara color plates), Scotopic pupil measurement (Colvard pupillometer), Slit lamp biomicroscopy of anterior segment, intraocular pressure measurement, dilated fundoscopic exam (2.5% phenylephrine and 0.5% tropicamide), and corneal topography (Pentacam).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and accuracy of Brillouin modulus measurement.</measure>
    <time_frame>at time of imaging session</time_frame>
    <description>It will be tested if, with the parameters designed for in vivo operation, the Brillouin ocular analyzer is sensitive enough to characterize the elasticity of cornea and crystalline lens as well as its spatial distribution within the ocular tissue.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Measurement of the Elasticity of the Anterior Eye Segment</condition>
  <arm_group>
    <arm_group_label>Normal Healthy Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brillouin Ocular Analyser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Brillouin Ocular Analyser</intervention_name>
    <description>Measurement of the local viscoelastic properties (Brillouin Shift) of the Anterior Eye Segment.</description>
    <arm_group_label>Normal Healthy Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers aged 20-60

          -  No refractional abnormalities

          -  Clear enough cornea and media to permit imaging

        Exclusion Criteria:

          -  Occludable narrow angles (without a patent peripheral iridotomy)

          -  Other ocular or systemic pathology, which precludes safe eye dilation

          -  LASIK eye surgery

          -  Allergies to the dilation medication

          -  Only one healthy eye

          -  Pregnant women or expected pregnancy within the timeframe of the study

          -  Do not or cannot understand the instructions for the imaging

          -  Restricted mobility
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seok H Yun, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natalia Perrotta</last_name>
    <phone>617-768-8705</phone>
    <email>nperrotta@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sebastien Besner, PhD</last_name>
    <phone>617-724-6798</phone>
    <email>sbesner@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts Eye and Ear Infirmary</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberto Pineda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Perrotta</last_name>
      <phone>617-768-8705</phone>
      <email>nperrotta@partners.org</email>
    </contact>
    <investigator>
      <last_name>Sebastien Besner, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giuliano Scarcelli, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seok H Yun, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mehron Puoris'haag, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Scarcelli G, Yun SH. In vivo Brillouin optical microscopy of the human eye. Opt Express. 2012 Apr 9;20(8):9197-202. doi: 10.1364/OE.20.009197.</citation>
    <PMID>22513631</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2013</study_first_submitted>
  <study_first_submitted_qc>January 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2013</study_first_posted>
  <last_update_submitted>January 22, 2013</last_update_submitted>
  <last_update_submitted_qc>January 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Seok Hyun Yun</investigator_full_name>
    <investigator_title>Associate Physicist / Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Lens</keyword>
  <keyword>Cornea</keyword>
  <keyword>Stiffness</keyword>
  <keyword>Brillouin Shift</keyword>
  <keyword>Young Modulus</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

